Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Astrazeneca Plc ADR
(NQ:
AZN
)
78.59
+0.47 (+0.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Astrazeneca Plc ADR
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
55
56
Next >
AstraZeneca PLC (NASDAQ: AZN) Records 52-Week High Friday Morning
April 21, 2023
Via
Investor Brand Network
A Look Into AstraZeneca's Debt
April 19, 2023
Via
Benzinga
Could This Rare-Disease Drug Candidate Become a Blockbuster?
April 19, 2023
This drug candidate could be a great treatment option for patients with a potentially deadly disease.
Via
The Motley Fool
Price Over Earnings Overview: AstraZeneca
April 18, 2023
Via
Benzinga
Why AstraZeneca Shares Are Trading Higher Today?
April 18, 2023
AstraZeneca plc's (NASDAQ: AZN) vaccine head highlighted the confidence that the company's new COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants.
Via
Benzinga
AstraZeneca PLC (NASDAQ: AZN) Records 52-Week High Tuesday Morning
April 18, 2023
Via
Investor Brand Network
Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So
April 18, 2023
On their own, cancer or diabetes can be debilitating and deadly. The two are common diseases with tremendous impact on health worldwide.
Via
Benzinga
Here's How Much $1000 Invested In AstraZeneca 5 Years Ago Would Be Worth Today
April 17, 2023
Via
Benzinga
AstraZeneca Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 17, 2023
Via
Benzinga
IMFINZI-based treatment before and after surgery reduced the risk of disease recurrence, progression events or death by 32% in resectable non-small cell lung cancer in the AEGEAN Phase III trial
April 16, 2023
From
AstraZeneca
Via
Business Wire
3 Healthcare Dividend Payers With Big Price Growth
April 14, 2023
Sanofi, AstraZeneca and Smith & Nephew all boast price performance better than about 80% of the broader market, and all are dividend payers.
Via
MarketBeat
Argus Research Maintains Buy Rating for AstraZeneca: Here's What You Need To Know
April 13, 2023
Via
Benzinga
AstraZeneca PLC (NASDAQ: AZN) Sets New 52-Week High in Wednesday Session
April 12, 2023
Via
Investor Brand Network
$1000 Invested In AstraZeneca 5 Years Ago Would Be Worth This Much Today
April 12, 2023
Via
Benzinga
2 Top Biotech Stocks to Buy Right Now
April 07, 2023
These two companies pay market-beating dividends to shareholders.
Via
The Motley Fool
AstraZeneca PLC (NASDAQ: AZN) Climbs to New 52-Week High
April 06, 2023
Via
Investor Brand Network
Check Out What Whales Are Doing With AZN
April 05, 2023
Via
Benzinga
Biden Administration Launches $5B Program To Boost Development Of Pan-Coronavirus Vaccine, Treatments
April 11, 2023
The White House plans to devote $5 billion to develop effective treatments and vaccines against current and future Covid variants, a Department of Health and Human Services (HHS) spokesperson and a...
Via
Benzinga
AstraZeneca reinforces commitment to advancing science for patients with chronic kidney disease and hyperkalemia at NKF Spring Clinical Meeting 2023
April 11, 2023
From
AstraZeneca
Via
Business Wire
Canadian Cancer Diagnostic Company BioMark Working On Early Lung Detection Assay
April 10, 2023
Via
Benzinga
7 Very Undervalued Penny Stocks to Buy in April 2023
April 06, 2023
Undervalued penny stocks present investors who are very bullish on the near-term future with a high-risk, high-reward option.
Via
InvestorPlace
Astrazeneca Plc (NASDAQ: AZN) Highlighted for Surprising Price Action
April 05, 2023
Via
Investor Brand Network
A Look Into AstraZeneca Inc's Price Over Earnings
March 31, 2023
Via
Benzinga
A Look Into AstraZeneca's Debt
March 31, 2023
Via
Benzinga
Medical Behemoth AstraZeneca Flirts With Breakout On Fresh Hope In Ovarian Cancer
April 05, 2023
A combination of four drugs improved outcomes in ovarian cancer treatment.
Via
Investor's Business Daily
AstraZeneca' Cancer Drug Combo Meets Goal In Late-Stage Ovarian Cancer Study
April 05, 2023
Via
Benzinga
COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All
March 31, 2023
Effective treatments for COVID-19 remain very few and very limited in their capabilities, even after three years. As a result, there are still high rates of hospitalizations and COVID remains many...
Via
Benzinga
7 Growth Stocks That Pay Generous Dividends
March 30, 2023
With these seven dividend-paying growth stocks, steady payouts plus underlying growth could produce strong long-term total returns.
Via
InvestorPlace
Pieris Pharma Pushes Elarekibep Data Readout, Investors React Negatively
March 29, 2023
Via
Benzinga
AstraZeneca Axes Pneumonia Drug Pact With Aridis
March 29, 2023
AstraZeneca plc (NASDAQ: AZN) scrapped its license agreement with Aridis Pharmaceuticals Inc (NASDAQ: ARDS).
Via
Benzinga
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
55
56
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.